Lack of expression of MTAP in uncommon T-Cell lymphomas

Clinical Lymphoma, Myeloma and Leukemia

Volumn 12, Issue 5, 2012, Pages 306-309

  Bertino, Joseph R ^a   Lubin, Martin ^b   Johnson Farley, Nadine ^a   Chan, Wing C ^c   Goodell, Lauri ^a   Bhagavathi, Sharathkumar ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Methylthioadenosine phosphorylase; Peripheral T cell lymphoma; Pralatrexate

Indexed keywords

5' METHYLTHIOADENOSINE; 5' METHYLTHIOADENOSINE PHOSPHORYLASE; PRALATREXATE; TIOGUANINE;

ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG MEGADOSE; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; LYMPHATIC LEUKEMIA; LYMPHOBLASTOMA; PERIPHERAL T CELL LYMPHOMA; PURINE SYNTHESIS; T CELL LEUKEMIA; T CELL LYMPHOMA; TREATMENT OUTCOME;

ADENINE; AMINOPTERIN; FOLIC ACID ANTAGONISTS; HUMANS; LYMPHOMA, T-CELL; PURINE-NUCLEOSIDE PHOSPHORYLASE; PURINES; THIOGUANINE; TISSUE ARRAY ANALYSIS;

EID: 84867419169     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2012.07.001     Document Type: Article

References (17)

1. J.R. Bertino, W.R. Waud, W.B. Parker Targeting tumors that lack methylthioadenosine phosphorylase (MTAP) activity: current strategies Cancer Biol Ther 11 2011 627 632
2. T.J. M'Soka, J. Nishioka, A. Taga Detection of methylthioadenosine phosphorylase (MTAP) and p16 gene deletion in T-cell acute lymphoblastic leukemia by real time quantitative PCR assay Leukemia 14 2000 935 940
3. A. Batova, M.B. Diccianni, T. Nobori Frequent deletion in the methylthioadenosine phosphorylase gene in T-cell acute lymphoblastic leukemia: strategies for enzyme targeted therapy Blood 15 1966 3083 3090
4. C. Hellerbrand, M. Mühlbauer, S. Wallner Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma Carcinogenesis 27 2006 64 72
5. J.X. Dou, W.D. Zhang, H.L. Li Expression of methylthioadenosine phosphorylase (MTAP) gene and demethylation of its promoter in human colorectal cancer [in Japanese] Ai Zheng 4 2009 390 394
6. J. Kim, M.A. Kim, S.Y. Min Downregulation of methylthioadenosin phosphorylase by homozygous deletion in gastric carcinoma Genes Chromosomes Cancer 50 2011 421 433
7. Y. Kadariya, B. Yin, B. Tang Mice heterozygous for germ-line mutations in methylthioadenosine phosphorylase (MTAP) die prematurely of T-cell lymphoma Cancer Res 69 2009 5961 5969
8. S.A. Christopher, P. Diegelman, C.W. Porter Methylthioadenosine phosphorylase, a gene frequently codeleted with p16(cdkN2a/ARF), acts as a tumor suppressor in a breast cancer cell line Cancer Res 62 2002 6639 6644
9. M.H. Dreyling, D. Roulston, S.K. Bohlander, J. Vardiman Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma Genes Chromosomes Cancer 22 1998 72 78
10. S. Marcé, O. Balagué, L. Colomo Lack of methylthioadenosine phosphorylase expression in mantle cell lymphoma is associated with shorter survival: implications for a potential targeted therapy Clin Cancer Res 12 2006 3754 3761
11. H.Y. Huang, S.H. Li, S.C. Yu Homozygous deletion of MTAP gene as a poor prognosticator in gastrointestinal stromal tumors Clin Cancer Res 15 2009 6963 6972 2011
12. Z.H. Chen, O.I. Olopade, T.M. Savarese Expression of methylthioadenosine phosphorylase cDNA in p16-, MTAP- malignant cells: restoration of methylthioadenosine phosphorylase-dependent salvage pathways and alterations of sensitivity to inhibitors of purine de novo synthesis Mol Pharmacol 52 1997 903 911
13. T. Efferth, H. Miyachi, H.G. Drexler Methylthioadenosine phosphorylase as target for chemoselective treatment of T-cell acute lymphoblastic leukemic cells Blood Cells Mol Dis 28 2002 47 56
14. H.L. Kindler, H.A. Burris, A.B. Sandler A phase II multicenter study of L-alanosine, a potent inhibitor of adenine biosynthesis, in patients with MTAP-deficient cancer Invest New Drugs 27 2009 75 81
15. O.A. O'Connor, B. Pro, L. Pinter-Brown Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study J Clin Oncol 29 2011 1182 1189
16. F.M. Foss, S. Horwitz, L. Pinter-Brown Pralatrexate is an effective treatment for heavily pretreated patients with relapsed/refractory transformed mycosis fungoides Blood 116 2010 735 abstract
17. G. Kirovski, A.P. Stevens, B. Czech Down-regulation of methylthioadenosine phosphorylase (MTAP) induces progression of hepatocellular carcinoma via accumulation of 5'-deoxy-5'-methylthioadenosine (MTA) Am J Pathol 178 2011 1145 1152